162 related articles for article (PubMed ID: 38632187)
1. Partial mGlu
Pałucha-Poniewiera A; Rafało-Ulińska A; Santocki M; Babii Y; Kaczorowska K
Pharmacol Rep; 2024 Jun; 76(3):504-518. PubMed ID: 38632187
[TBL] [Abstract][Full Text] [Related]
2. Partial mGlu₅ Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects.
Gould RW; Amato RJ; Bubser M; Joffe ME; Nedelcovych MT; Thompson AD; Nickols HH; Yuh JP; Zhan X; Felts AS; Rodriguez AL; Morrison RD; Byers FW; Rook JM; Daniels JS; Niswender CM; Conn PJ; Emmitte KA; Lindsley CW; Jones CK
Neuropsychopharmacology; 2016 Mar; 41(4):1166-78. PubMed ID: 26315507
[TBL] [Abstract][Full Text] [Related]
3. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
Koike H; Fukumoto K; Iijima M; Chaki S
Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
[TBL] [Abstract][Full Text] [Related]
4. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
[TBL] [Abstract][Full Text] [Related]
5. Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling.
Qu Y; Shan J; Wang S; Chang L; Pu Y; Wang X; Tan Y; Yamamoto M; Hashimoto K
Eur Arch Psychiatry Clin Neurosci; 2021 Apr; 271(3):439-446. PubMed ID: 33180200
[TBL] [Abstract][Full Text] [Related]
6. Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine.
Dong C; Zhang JC; Yao W; Ren Q; Ma M; Yang C; Chaki S; Hashimoto K
Int J Neuropsychopharmacol; 2017 Mar; 20(3):228-236. PubMed ID: 27765808
[TBL] [Abstract][Full Text] [Related]
7. Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling.
Wei Y; Chang L; Hashimoto K
Eur Neuropsychopharmacol; 2021 Sep; 50():55-63. PubMed ID: 33971385
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.
Zhang JC; Yao W; Dong C; Yang C; Ren Q; Ma M; Han M; Hashimoto K
Psychopharmacology (Berl); 2015 Dec; 232(23):4325-35. PubMed ID: 26337614
[TBL] [Abstract][Full Text] [Related]
9. Two standardized fractions of Gardenia jasminoides Ellis with rapid antidepressant effects are differentially associated with BDNF up-regulation in the hippocampus.
Ren L; Tao W; Zhang H; Xue W; Tang J; Wu R; Xia B; Wu H; Chen G
J Ethnopharmacol; 2016 Jul; 187():66-73. PubMed ID: 27108051
[TBL] [Abstract][Full Text] [Related]
10. Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine.
Xiong Z; Zhang K; Ishima T; Ren Q; Ma M; Pu Y; Chang L; Chen J; Hashimoto K
Pharmacol Biochem Behav; 2019 Jan; 176():57-62. PubMed ID: 30502360
[TBL] [Abstract][Full Text] [Related]
11. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
[TBL] [Abstract][Full Text] [Related]
12. VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy.
Nickols HH; Yuh JP; Gregory KJ; Morrison RD; Bates BS; Stauffer SR; Emmitte KA; Bubser M; Peng W; Nedelcovych MT; Thompson A; Lv X; Xiang Z; Daniels JS; Niswender CM; Lindsley CW; Jones CK; Conn PJ
J Pharmacol Exp Ther; 2016 Jan; 356(1):123-36. PubMed ID: 26503377
[TBL] [Abstract][Full Text] [Related]
13. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
Koike H; Iijima M; Chaki S
Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
[TBL] [Abstract][Full Text] [Related]
14. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E
Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718
[TBL] [Abstract][Full Text] [Related]
15. Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors.
Nowak G; Pomierny-Chamioło L; Siwek A; Niedzielska E; Pomierny B; Pałucha-Poniewiera A; Pilc A
Neuropharmacology; 2014 Sep; 84():46-51. PubMed ID: 24796254
[TBL] [Abstract][Full Text] [Related]
16. Partial mGlu
Holter KM; Lekander AD; LaValley CM; Bedingham EG; Pierce BE; Sands LP; Lindsley CW; Jones CK; Gould RW
Front Neurosci; 2021; 15():700822. PubMed ID: 34276300
[TBL] [Abstract][Full Text] [Related]
17. Combined Administration of (
Rafało-Ulińska A; Brański P; Pałucha-Poniewiera A
Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215237
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms for the antidepressant-like effects of a low-dose ketamine treatment in a DFP-based rat model for Gulf War Illness.
Ribeiro ACR; Zhu J; Kronfol MM; Jahr FM; Younis RM; Hawkins E; McClay JL; Deshpande LS
Neurotoxicology; 2020 Sep; 80():52-59. PubMed ID: 32592718
[TBL] [Abstract][Full Text] [Related]
19. Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology.
Sengmany K; Hellyer SD; Albold S; Wang T; Conn PJ; May LT; Christopoulos A; Leach K; Gregory KJ
Neuropharmacology; 2019 May; 149():83-96. PubMed ID: 30763654
[TBL] [Abstract][Full Text] [Related]
20. Sigma-1 receptor activation mediates the sustained antidepressant effect of ketamine in mice via increasing BDNF levels.
Ma H; Li JF; Qiao X; Zhang Y; Hou XJ; Chang HX; Chen HL; Zhang Y; Li YF
Acta Pharmacol Sin; 2024 Apr; 45(4):704-713. PubMed ID: 38097715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
